CEACAM5 and neoplasm: Compared with the AJCC 8th TNM stage, our clinical prediction model based on serum tumor markers and other clinicopathological features had more accurate predictive power and better clinical applicability, and it served as a potent tool for forecasting the postoperative overall survival outcomes of stage I–III CRC patients after radical resection with normal preoperative CEA.